These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19075070)

  • 21. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
    Stone JA; Holland SD; Wickersham PJ; Sterrett A; Schwartz M; Bonfiglio C; Hesney M; Winchell GA; Deutsch PJ; Greenberg H; Hunt TL; Waldman SA
    Antimicrob Agents Chemother; 2002 Mar; 46(3):739-45. PubMed ID: 11850256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
    Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
    Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
    Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin.
    Krishna G; Vickery D; Ma L; Yu X; Noren C; Power E; Beresford E; Medlock M
    J Clin Pharmacol; 2011 Jan; 51(1):84-92. PubMed ID: 20489029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal liver abscesses due to Candida infection effectively treated with caspofungin.
    Filippi L; Poggi C; Gozzini E; Meleleo R; Mirabile L; Fiorini P
    Acta Paediatr; 2009 May; 98(5):906-9. PubMed ID: 19187395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
    Würthwein G; Cornely OA; Trame MN; Vehreschild JJ; Vehreschild MJ; Farowski F; Müller C; Boos J; Hempel G; Hallek M; Groll AH
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1664-71. PubMed ID: 23335740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Hope WW; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
    J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspofungin: a review of its use in the treatment of fungal infections.
    McCormack PL; Perry CM
    Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspofungin acetate: an antifungal agent.
    Hoang A
    Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit.
    Nguyen TH; Hoppe-Tichy T; Geiss HK; Rastall AC; Swoboda S; Schmidt J; Weigand MA
    J Antimicrob Chemother; 2007 Jul; 60(1):100-6. PubMed ID: 17525052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of an elevated dosage of micafungin in premature neonates.
    Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK
    Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of micafungin in neonates and young infants.
    Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients.
    Würthwein G; Young C; Lanvers-Kaminsky C; Hempel G; Trame MN; Schwerdtfeger R; Ostermann H; Heinz WJ; Cornely OA; Kolve H; Boos J; Silling G; Groll AH
    Antimicrob Agents Chemother; 2012 Jan; 56(1):536-43. PubMed ID: 22083471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspofungin.
    Keating GM; Jarvis B
    Drugs; 2001; 61(8):1121-9; discussion 1130-1. PubMed ID: 11465873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspofungin therapy in immunocompromised children and neonates.
    Somer A; Törün SH; Salman N
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):347-55. PubMed ID: 21417874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.